showed that maternal treatment at a later stage in pregnancy is also beneficial for neonatal outcome.
In this study, the offspring of
women who had an ongoing increase
in maternal serum fT4 from 12 to 32 weeks’ gestation showed neurodevelopment at one and two years of age that was not significantly different from that of controls.15
Other investigators have noted similar benefits with treatment of maternal hypothyroidism.